Scotland’s medicines bill can shrink further, says report
January 25, 2013Sales and Marketing PPRS, Scotland, VBP, prescribing
An official review of primary care prescribing in Scotland has welcomed savings made, but says further efficiencies are possible.Audit Scotland …
Abbott finishes strongly before spin-off
January 25, 2013Sales and Marketing AbbVie, Abbott, Q4 2012
Abbott has presented its full-year results for 2012 – the last in which many of its products will appear, following …
NICE recommends two cystic fibrosis treatments
January 25, 2013Sales and Marketing Colobreath, Forest Labs, Novartis, Tobi Podhaler, cystic fibrosis
NICE has given final recommendation to two new inhalers for cystic fibrosis (CF) patients.Forest Lab’s Colobreath (colistimethate sodium) and Novartis’ …
Allergan in $958m neurology deal
January 25, 2013Sales and Marketing Allergan, CNS, MAP Pharmaceuticals, migraine
Allergan is to pay $958m for MAP Pharmaceuticals in a deal which sees both companies hoping to reap the benefits …
Flying start to 2013 for Watermeadow Medical
January 24, 2013Medical Communications
Watermeadow Medical has started the new year with an office relocation from Knutsford to fully refurbished, larger office space in …
Novartis’ 2012 results flat
January 24, 2013Sales and Marketing Bexsero, Jakavi, Novartis, generics, results
Generic competition has put a dent in Novartis’ financial results for 2012, with net sales down 3% year on year …
EU approval for Novo Nordisk diabetes drugs
January 24, 2013Sales and Marketing Novo Nordisk, Ryzodeg, Tresiba
Novo Nordisk is celebrating after European regulators approved two of its drugs for the treatment of adults with diabetes. The …
Jörg Reinhardt to leave Bayer for Novartis
January 24, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, Novartis, Reinhardt
The chairman of the Board and member of the Bayer executive council Dr Jörg Reinhard is stepping down from his …
Watson buys women’s health specialists
January 23, 2013Research and Development, Sales and Marketing Actavis, Uteron, Watson, women
Watson has completed the acquisition of Uteron Pharma, a Belgium R&D-based firm specialising in women’s health products. The world’s third-largest …
EU approval for meningitis vaccine
January 23, 2013Sales and Marketing Bexsero, CHMP, Novartis, meningitis
European regulators have approved Novartis’ Bexsero, making it the first broad coverage vaccine to target the leading cause of meningitis. …
New drug discovery alliance launches
January 23, 2013Research and Development, Sales and Marketing CDRD, LDC, translational research
Six of the world’s top health science centres have banded together in an attempt to speed up the rate at …
Roche adds head to corporate executive committee
January 23, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing John Reed, Roche
Roche has announced that John Reed has been appointed as head of Roche Pharma Research and Early Development (pRED) and …
Ark Therapeutics mulling fundraising options
January 22, 2013Manufacturing and Production Ark Therapeutics
Contract development and manufacturing services company Ark Therapeutics has been forced to abandon proposals to raise money via an equity …
Germany’s Hameln warned by FDA over GMP failings
January 22, 2013Manufacturing and Production FDA, GMP, Hameln
German contract manufacturer Hameln Pharmaceuticals was sent a warning letter by the FDA last month detailing a number of Good …
Botox US bladder indication
January 22, 2013Sales and Marketing Allergan, Botox, FDA, bladder
Allergan’s Botox has been given approval by the FDA for the treatment of overactive bladder (OAB) in adults.Botox (onabotulinumtoxinA) has …
Lundbeck sells $100m portfolio
January 22, 2013Sales and Marketing Lundbeck, OTC, Panhematin, Recordati
Italian pharma group Recordati has paid $80 million to Lundbeck for a portfolio of products primarily aimed at the US …
New appointment and promotions at Events 4 Healthcare
January 22, 2013Medical Communications, Sales and Marketing Events 4 Healthcare
Comms agency Events 4 Healthcare has announced two new promotions and a new appointment to further enhance its team. Nicola …
Novartis eye drug nears approval
January 21, 2013Sales and Marketing AMD, CHMP, Jetria, Novartis
Novartis’ eye drug Jetrea has been given a positive opinion by the CHMP, pushing it to the brink of approval. …
CHMP nod for Pfizer CML drug
January 21, 2013Sales and Marketing CHMP, CML, FDA, Pfizer
Pfizer’s cancer drug bosutinib has been given a positive opinion by the CHMP for patients with chronic myelogenous leukemia (CML). …
Crohn’s and Colitis UK hire new chief executive
January 21, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Crohn's and Colitis, David Barker
The medical charity Crohn’s and Colitis UK Trustees have announced the appointment of David Barker as the new chief executive …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
